We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
1651
Arrowhead Research
ARWR
$12.1B
$13K ﹤0.01%
325
-1,562
-83% -$51.8K
HSBC icon
1652
HSBC
HSBC
$355B
$13K ﹤0.01%
405
+17
+4% +$482
SAP icon
1653
SAP
SAP
$187B
$13K ﹤0.01%
124
-17
-12% -$1.7K
CLVS
1654
DELISTED
Clovis Oncology, Inc.
CLVS
$13K ﹤0.01%
250,200
TWOU
1655
DELISTED
2U Inc
TWOU
$12.1K ﹤0.01%
65
-36
-36% -$7.14K
BBVA icon
1656
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$12K ﹤0.01%
2,037
+98
+5% +$529
FNV icon
1657
Franco-Nevada
FNV
$41.4B
$11K ﹤0.01%
+77
New +$10.2K
PUK icon
1658
Prudential
PUK
$36.5B
$11K ﹤0.01%
401
+30
+8% +$686
SU icon
1659
Suncor Energy
SU
$77.7B
$11K ﹤0.01%
360
-35
-9% -$1.15K
EMBC icon
1660
Embecta
EMBC
$195M
$10.3K ﹤0.01%
410
+42
+11% +$1.28K
SHOE
1661
Shoe Station Group
SHOE
$395M
$10K ﹤0.01%
400
ATNX
1662
DELISTED
Athenex, Inc. Common Stock
ATNX
$10K ﹤0.01%
3,500
GMVD
1663
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$9.51K ﹤0.01%
2,925
+1
+0% +$5
LBRDA icon
1664
Liberty Broadband Class A
LBRDA
$4.14B
$9.4K ﹤0.01%
124
AVD icon
1665
American Vanguard Corp
AVD
$73.5M
$8K ﹤0.01%
389
ING icon
1666
ING
ING
$93.8B
$8K ﹤0.01%
671
+29
+5% +$315
IX icon
1667
ORIX
IX
$44B
$8K ﹤0.01%
490
+20
+4% +$304
UL icon
1668
Unilever
UL
$131B
$8K ﹤0.01%
132
+44
+50% +$2.35K
DEO icon
1669
Diageo
DEO
$46.2B
$7K ﹤0.01%
42
+3
+8% +$526
HLN icon
1670
Haleon
HLN
$43.1B
$7K ﹤0.01%
833
-212,831
-100% -$1.45M
KD icon
1671
Kyndryl
KD
$2.66B
$7K ﹤0.01%
656
-7,466
-92% -$75.1K
CINC
1672
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$7K ﹤0.01%
609
KURA icon
1673
Kura Oncology
KURA
$922M
$6K ﹤0.01%
469
-517
-52% -$7.51K
SNN icon
1674
Smith & Nephew
SNN
$12.9B
$6K ﹤0.01%
228
NVO
1675
Novo Nordisk
NVO
$216B
$4K ﹤0.01%
56
-78
-58% -$4.57K

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.